PHYSICIAN FORMULATED VEYETAMINS HELPINGIN THE PREVENTION OF MACULAR DEGENERATIVE EYE DISEASE - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
75915173
Word Mark
PHYSICIAN FORMULATED VEYETAMINS HELPINGIN THE PREVENTION OF MACULAR DEGENERATIVE EYE DISEASE
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2003-03-12
Filing Date
2000-01-31
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
Typeset
Design Searches
260103 - Incomplete circles (more than semi-circles).
Law Office Assigned Location Code
L50
Employee Name
BROWN, BRIAN D
Statements
Disclaimer with Predetermined Text
PHYSICIAN FORMULATED and HELPING IN THE PREVENTION OF MACULAR DEGENERATIVE EYE DISEASE
Goods and Services
vitamin and mineral supplement
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2000-02-29
Primary Code
005
Correspondences
Name
MACKMAN BARBARA ANN
Address
Please log in with your Justia account to see this address.
Trademark Events
Event Date | Event Description |
2000-06-29 | ASSIGNED TO EXAMINER |
2000-07-17 | NON-FINAL ACTION MAILED |
2001-02-23 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
2001-03-26 | PETITION TO REVIVE-RECEIVED |
2002-01-02 | PETITION TO REVIVE-GRANTED |
2002-07-16 | FINAL REFUSAL MAILED |
2002-10-08 | ASSIGNED TO EXAMINER |
2003-03-12 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |